Montauk RRG
Major Rating Factors:
Fair long-term capitalization index (3.5 on a scale of 0 to 10) based on weak current risk adjusted capital (moderate loss scenarios), although results have slipped from the good range during the last year. Weak overall results on stability tests (0.0) including weak results on operational trends, weak risk diversification and negative cash flow from operations for 2025. The largest net exposure for one risk is excessive at 99.2% of capital. Fair profitability index (3.4) with operating losses during 2022.
Other Rating Factors:
History of adequate reserve strength (6.0) as reserves have been consistently at an acceptable level. Good liquidity (6.9) with sufficient resources (cash flows and marketable investments) to handle a spike in claims.
Stability Factors:
C - Past results on our Risk-Adjusted Capital tests.
D - Limited diversification of general business, policy, and/or investment risk.
F - Negative cash flow.
T - Significant trends in critical asset, liability, income or expense items.
Principal Lines of Business:
Med mal (43.4%), other (56.6%)
Licensed in:
VT
Principal Investments:
Investment grade bonds (62.8%), common stock (26.6%), cash (2.7%), other (7.8%)
Corporate Info
Group Affiliation
None
Investment Rating
--
Company Address
463 Mountain View Drive
Colchester, VT 05446
Colchester, VT 05446
Phone Number
(802) 864-5599
NAIC Number
16218
Website
--
Largest Affiliates
There are no affiliate to display.